Apellis Pharmaceuticals Reports First Quarter 2023 Financial Results
Provided By Globe Newswire
Last update: May 4, 2023
WALTHAM, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced its first quarter 2023 financial results and business highlights.
Read more at globenewswire.com
